Balaxi Pharmaceuticals Limited

NSEI:BALAXI Voorraadrapport

Marktkapitalisatie: ₹4.0b

Balaxi Pharmaceuticals Beheer

Beheer criteriumcontroles 3/4

De CEO Balaxi Pharmaceuticals is Ashish Maheshwari, benoemd in May2017, heeft een ambtstermijn van 7.5 jaar. De totale jaarlijkse vergoeding van { bedraagt ₹ 8.25M, bestaande uit 97% salaris en 3% bonussen, inclusief aandelen en opties van het bedrijf. bezit rechtstreeks 1.78% van de aandelen van het bedrijf, ter waarde ₹ 68.38M. De gemiddelde ambtstermijn van het managementteam en de raad van bestuur bedraagt respectievelijk 4.8 jaar en 7.5 jaar.

Belangrijke informatie

Ashish Maheshwari

Algemeen directeur

₹8.3m

Totale compensatie

Percentage CEO-salaris97.0%
Dienstverband CEO7.5yrs
Eigendom CEO1.8%
Management gemiddelde ambtstermijn4.8yrs
Gemiddelde ambtstermijn bestuur7.5yrs

Recente managementupdates

Recent updates

Balaxi Pharmaceuticals (NSE:BALAXI) Strong Profits May Be Masking Some Underlying Issues

Nov 13
Balaxi Pharmaceuticals (NSE:BALAXI) Strong Profits May Be Masking Some Underlying Issues

These 4 Measures Indicate That Balaxi Pharmaceuticals (NSE:BALAXI) Is Using Debt Reasonably Well

Jul 30
These 4 Measures Indicate That Balaxi Pharmaceuticals (NSE:BALAXI) Is Using Debt Reasonably Well

Balaxi Pharmaceuticals Limited's (NSE:BALAXI) Share Price Could Signal Some Risk

May 29
Balaxi Pharmaceuticals Limited's (NSE:BALAXI) Share Price Could Signal Some Risk

Market Might Still Lack Some Conviction On Balaxi Pharmaceuticals Limited (NSE:BALAXI) Even After 38% Share Price Boost

Feb 10
Market Might Still Lack Some Conviction On Balaxi Pharmaceuticals Limited (NSE:BALAXI) Even After 38% Share Price Boost

Balaxi Pharmaceuticals (NSE:BALAXI) Has A Pretty Healthy Balance Sheet

Feb 09
Balaxi Pharmaceuticals (NSE:BALAXI) Has A Pretty Healthy Balance Sheet

Is Balaxi Pharmaceuticals (NSE:BALAXI) A Risky Investment?

Aug 08
Is Balaxi Pharmaceuticals (NSE:BALAXI) A Risky Investment?

The Trend Of High Returns At Balaxi Pharmaceuticals (NSE:BALAXI) Has Us Very Interested

May 20
The Trend Of High Returns At Balaxi Pharmaceuticals (NSE:BALAXI) Has Us Very Interested

A Look At The Intrinsic Value Of Balaxi Pharmaceuticals Limited (NSE:BALAXI)

Feb 03
A Look At The Intrinsic Value Of Balaxi Pharmaceuticals Limited (NSE:BALAXI)

Calculating The Intrinsic Value Of Balaxi Pharmaceuticals Limited (NSE:BALAXI)

Sep 06
Calculating The Intrinsic Value Of Balaxi Pharmaceuticals Limited (NSE:BALAXI)

Balaxi Pharmaceuticals (NSE:BALAXI) Knows How To Allocate Capital Effectively

Jun 03
Balaxi Pharmaceuticals (NSE:BALAXI) Knows How To Allocate Capital Effectively

Is Weakness In Balaxi Pharmaceuticals Limited (NSE:BALAXI) Stock A Sign That The Market Could be Wrong Given Its Strong Financial Prospects?

Mar 12
Is Weakness In Balaxi Pharmaceuticals Limited (NSE:BALAXI) Stock A Sign That The Market Could be Wrong Given Its Strong Financial Prospects?

Is Balaxi Pharmaceuticals Limited's(NSE:BALAXI) Recent Stock Performance Tethered To Its Strong Fundamentals?

Nov 27
Is Balaxi Pharmaceuticals Limited's(NSE:BALAXI) Recent Stock Performance Tethered To Its Strong Fundamentals?

Analyse CEO-vergoeding

Hoe is Ashish Maheshwari's beloning veranderd ten opzichte van Balaxi Pharmaceuticals's winst?
DatumTotale vergoedingSalarisBedrijfswinsten
Sep 30 2024n/an/a

₹356m

Jun 30 2024n/an/a

₹454m

Mar 31 2024₹8m₹8m

-₹24m

Dec 31 2023n/an/a

-₹52m

Sep 30 2023n/an/a

-₹106m

Jun 30 2023n/an/a

-₹95m

Mar 31 2023n/an/a

₹460m

Dec 31 2022n/an/a

₹506m

Sep 30 2022n/an/a

₹545m

Jun 30 2022n/an/a

₹511m

Mar 31 2022₹3m₹3m

₹477m

Dec 31 2021n/an/a

₹433m

Sep 30 2021n/an/a

₹421m

Jun 30 2021n/an/a

₹401m

Mar 31 2021₹3m₹3m

₹381m

Dec 31 2020n/an/a

₹312m

Sep 30 2020n/an/a

₹228m

Jun 30 2020n/an/a

₹138m

Mar 31 2020₹3m₹3m

₹61m

Compensatie versus markt: De totale vergoeding ($USD 97.64K ) Ashish } ligt boven het gemiddelde voor bedrijven van vergelijkbare omvang in de Indian markt ($USD 42.67K ).

Compensatie versus inkomsten: De vergoeding van Ashish is het afgelopen jaar in lijn geweest met de bedrijfsprestaties.


CEO

Ashish Maheshwari (54 yo)

7.5yrs

Tenure

₹8,250,000

Compensatie

Mr. Ashish Maheshwari has been Managing Director and Executive Director of Balaxi Pharmaceuticals Limited (formerly known as Balaxi Ventures Limited) (formerly known as The Anandam Rubber Company Limited)...


Leiderschapsteam

NaamPositieTenureCompensatieEigendom
Ashish Maheshwari
MD & Executive Chairman7.5yrs₹8.25m1.78%
₹ 71.4m
Amol Mantri
CFO & Financial Controller4.8yrsgeen gegevensgeen gegevens
Piyush Maheshwari
President Operationsno datageen gegevensgeen gegevens
Mohith Khandelwal
Company Secretary & Compliance Officerno datageen gegevensgeen gegevens
Pranav Maheshwari
Senior Vice President of Business Development4.8yrsgeen gegevensgeen gegevens
Paridhi Maheshwari
Head of Alternate Channels4.8yrsgeen gegevensgeen gegevens
Jignesh Dinesh Shah
Finance Controller of Angolano datageen gegevensgeen gegevens
Pankaj Singh
Head of Operations of Guatemalano datageen gegevensgeen gegevens
Karan Kapoor
Head of Operations of Dominician Republicno datageen gegevensgeen gegevens
Laksh Shewakramani
Compliance Head of Angolano datageen gegevensgeen gegevens
Manish Jumnani
Sales Head of Guatemalano datageen gegevensgeen gegevens
Bharat Jawarani
Sales Head of Dominician Republicno datageen gegevensgeen gegevens

4.8yrs

Gemiddelde duur

Ervaren management: Het managementteam van BALAXI wordt beschouwd als ervaren (gemiddelde ambtstermijn 4.8 jaar).


Bestuursleden

NaamPositieTenureCompensatieEigendom
Ashish Maheshwari
MD & Executive Chairman7.5yrs₹8.25m1.78%
₹ 71.4m
Kunal Bhakta
Independent Non-Executive Director7.5yrs₹250.00k2.02%
₹ 81.2m
Akshita Surana
Non-Executive Independent Directorno datageen gegevensgeen gegevens
Minoshi Maheshwari
Non Executive Director7.5yrs₹250.00k1.04%
₹ 41.7m
Gandhi Gamji
Independent Non-Executive Director7.5yrs₹150.00kgeen gegevens
Mangina Rao
Independent Non-Executive Director4.2yrs₹250.00k0.098%
₹ 3.9m

7.5yrs

Gemiddelde duur

54yo

Gemiddelde leeftijd

Ervaren bestuur: De raad van bestuur van BALAXI wordt beschouwd als ervaren (gemiddelde ambtstermijn 7.5 jaar).